Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

How does tigecycline impact liver enzymes?

See the DrugPatentWatch profile for tigecycline

Short answer:
- Tigecycline can raise liver enzymes (ALT and AST) in some people, and there have been rare cases of more serious liver injury, including acute liver failure.
- Most enzyme elevations are mild and reversible after stopping the drug. More serious injury is uncommon but possible, so liver function monitoring is recommended.

Details:
- What happens to liver enzymes: In clinical use, increases in AST/ALT (and sometimes alkaline phosphatase or bilirubin) have been reported. The changes are generally in a minority of patients and are often mild.
- How often and how severe: Most elevations are mild and asymptomatic; serious liver injury is rare but has been observed. There have been reports of acute hepatic failure in association with tigecycline, though this is uncommon.
- Why it happens: The exact mechanism isn’t fully understood. It is considered a form of drug-induced liver injury (DILI) and may be idiosyncratic.
- Who’s at risk: Patients with preexisting liver disease or those taking other hepatotoxins may be at higher risk, but liver injury has occurred in people without prior liver issues as well.
- Monitoring and management:
- Baseline: Check liver function tests (ALT, AST, ALP, bilirubin) before starting therapy.
- During therapy: Repeat LFTs periodically, and sooner if symptoms arise.
- Signs to watch for: Jaundice (yellowing of skin/eyes), dark urine, pale stools, right upper abdominal pain, fatigue, nausea.
- If enzyme elevations become significant (for example, ALT/AST >3× ULN with symptoms or >5× ULN regardless of symptoms; or rising bilirubin with enzymes), stop tigecycline and evaluate for DILI.
- After stopping: LFTs typically improve if drug-induced; recovery may take days to weeks.
- Dosing in hepatic impairment: The label notes caution with hepatic impairment. In mild to moderate hepatic impairment, no dose adjustment is usually required, but severe hepatic impairment hasn’t been well studied and should be used with caution; monitor liver tests closely.

Practical takeaway:
- If you’re on tigecycline, expect baseline liver tests and periodic monitoring.
- Be alert for symptoms of liver trouble and contact a clinician promptly if they occur.
- If significant liver enzyme elevations occur, your clinician may stop the drug and manage the liver injury accordingly.

If you want, tell me your specific scenario (dose, duration, any symptoms, existing liver disease, other meds), and I can tailor the information. This is general guidance and not a substitute for medical advice.



Other Questions About Tigecycline :

evaluation of a potential tigecycline-warfarin drug interaction What strategies prevent tigecycline resistant infections in stewardship programs? How does higher tigecycline dosage impact liver enzymes? How can we prevent tigecycline overuse in healthcare? Does prolonged tigecycline use commonly raise liver enzymes? Can patients easily access tigecycline generics in rural areas? Can tigecycline be used to treat methicillin resistant staphylococcus aureus mrsa infections?